MDxHealth, Inc.
15279 Alton Parkway
Suite 100
Irvine
California
92618
United States
Tel: 949-812-6979
Fax: 949-242-2960
Website: http://www.mdxhealth.com/
Email: info@mdxhealth.com
249 articles about MDxHealth, Inc.
-
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
3/12/2024
MDxHealth SA, a commercial-stage precision diagnostic company, announces the introduction of a non-invasive genetic prostate cancer test through its urology sales channel.
-
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results
3/6/2024
MDxHealth SA, a commercial-stage precision diagnostics company, announced its financial results for the fourth quarter and year ended December 31, 2023.
-
Mdxhealth Announces Resignation of Board Member
2/16/2024
MDxHealth SA, a commercial-stage precision diagnostics company, announced that Jan Pensaert has stepped down from the Board of Directors of mdxhealth.
-
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance
1/8/2024
MDxHealth SA, a commercial-stage precision diagnostics company, reported preliminary fourth quarter and full year 2023 revenues and issued 2024 revenue guidance.
-
MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference
11/14/2023
MDxHealth SA, a commercial-stage precision diagnostics company, announced that Michael K. McGarrity, Chief Executive Officer, will participate in a fireside chat at the 35th Piper Sandler Healthcare Conference on Wednesday, November 29, 2023, at 9:00am ET.
-
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023
11/8/2023
MDxHealth SA, a commercial-stage precision diagnostics company, announced its financial results for the third quarter and nine-month period ended September 30, 2023.
-
MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8
10/25/2023
MDxHealth SA, a commercial-stage precision diagnostics company, announced it will release its financial results for the third quarter and nine-month period ended September 30, 2023, after market close on Wednesday, November 8, 2023.
-
Mdxhealth's New Share Capital Amount and New Number of Shares - October 20, 2023
10/20/2023
MDxHealth SA announces, in accordance with Article 15 of the Belgian Act of May 2, 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, that in the context of a capital increase completed on October 20, 2023, the Company's share capital has increased from EUR 163,471,629.58 to EUR 164,302,752.89.
-
MDxHealth Reports Preliminary Q3-2023 Revenues
10/9/2023
MDxHealth SA, a commercial-stage precision diagnostics company, reported preliminary third quarter 2023 revenues, units, and cash position.
-
MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting
10/2/2023
MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq andConvenes an Extraordinary General Shareholders Meeting
-
MDxHealth Reports Q2 and Half Year 2023 Results
8/23/2023
MDxHealth SA, a commercial-stage precision diagnostics company, announced its financial results for the second quarter and half year ended June 30, 2023.
-
MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23
8/10/2023
MDxHealth SA, a commercial-stage precision diagnostics company, announced it will release its financial results for the second quarter and half year ended June 30, 2023, after market close on Wednesday, August 23, 2023.
-
Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth’s Select mdx for Prostate Cancer Test
8/9/2023
MDxHealth SA, a commercial-stage precision diagnostics company, announced that Cigna has expanded commercial and Medicare Advantage coverage to include the Company’s Select mdx for Prostate Cancer test.
-
MDxHealth Announces Results of its Extraordinary General Shareholders’ Meeting
6/30/2023
MDxHealth SA, a commercial-stage precision diagnostics company, held an extraordinary general shareholders' meeting.
-
MDxHealth Announces its Extraordinary General Shareholders’ Meeting
6/5/2023
MDxHealth SA, a commercial-stage precision diagnostics company, invites the holders of securities issued by the Company to its extraordinary general shareholders' meeting that will be held on Friday, June 30, 2023 at 9:00 a.m., Belgian time.
-
MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference
5/23/2023
MDxHealth SA, a commercial-stage precision diagnostics company, announced that Michael McGarrity, Chief Executive Officer, will present at William Blair’s 43rd Annual Growth Stock Conference on Thursday, June 8, 2023, at 1:00pm ET.
-
MDxHealth Reports Q1-2023 Results
5/15/2023
MDxHealth SA, a commercial-stage precision diagnostics company, announced its financial results for the first quarter ended March 31, 2023.
-
MDxHealth to Present First Quarter 2023 Financial Results on May 15
5/1/2023
MDxHealth SA, a commercial-stage precision diagnostics company, announced it will release its financial results for the first quarter ended March 31, 2023, after market close on Monday, May 15, 2023.
-
Foundational LCD Covers Select mdx for Prostate Cancer
4/19/2023
MDxHealth SA, a commercial-stage precision diagnostics company, received notice that its Select mdx for Prostate Cancer test has successfully completed a rigorous technical assessment process with the Molecular Diagnostics Services Program developed by Palmetto GBA.
-
MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023
3/8/2023
MDxHealth SA, a commercial-stage precision diagnostics company, announced its financial results for the fourth quarter and year ended December 31, 2022, and provided a business update and outlook for 2023.